Equifax (EFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Fintel reports that on January 30, 2025, B of A Securities upgraded their outlook for Akero Therapeutics (NasdaqGS:AKRO) from ...

Akero Therapeutics (AKRO) stock was upgraded by Bank of America based on Phase 2 data the company shared for its liver disorder drug, efruxifermin. Read more here.

The Star Wars universe frequently adds new characters to a galaxy far, far away with fan-favorite comics like Doctor Aphra ...

As the U.S. stock market navigates a period of volatility, with recent declines following the Federal Reserve's decision to maintain interest rates amid persistent inflation and awaiting major tech ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...